Litigation Details for Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals, Inc. (D. Del. 2019)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals, Inc. (D. Del. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-06-17 |
Court | District Court, D. Delaware | Date Terminated | 2020-10-29 |
Cause | 28:2201 Declaratory Judgment | Assigned To | Leonard Philip Stark |
Jury Demand | None | Referred To | |
Patents | 9,187,405 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals, Inc.
Details for Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals, Inc. (D. Del. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-06-17 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,187,405. (ceg) (Entered: 06…2019 29 October 2020 1:19-cv-01118 830 Patent None District Court, D. Delaware | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |